Experimental model |
Ulnar defect in rabbit (not an osteoporosis model) |
Tibial osteotomy in overiectomized (OVX) sheep |
Mandibular defect in OVX rat |
Tibial defect in OVX rat |
Source of BMP |
rhBMP-2 |
Adenoviral transduction of mesenchymal stem cells and osteoblasts |
Transfection of bone marrow stromal cells with plasmid |
rhBMP-2 |
Carrier scaffold |
Polylactic glycolic acid/blood clot |
— |
Macroporous coral hydroxyapatite |
Absorbable collagen sponge |
Radiology |
Dose dependent response in the healing of defect |
QCT analyses showed larger cross-sectional callus area. |
Bone formation on the transfected bone marrow stromal cell seeded scaffold |
Mean radiological score was significantly higher in the BMP-2/OVX group than the only OVX group |
Biomechanics |
Torsion test revealed BMP-2 group more stiffer than the control but it was not dose dependent |
Bending and torsion tests showed stiffer callus tissue in the adenoviral BMP-2 group |
— |
Three-point bending test revealed higher load value in the BMP-2/OVX group than the its peer without BMP-2 application |
Histology |
Qualitative analyses revealed a dose dependent bone healing rate |
Quantitative analyses showed no difference between the groups in terms of the number of inflammatory cells |
Qualitative analyses showed the critic size defect completely filled by the trabecular bone at the end of 8-week in experimental group |
Quantitative analyses revealed superior callus formation (better bone union, cortex remodeling and callus formation) in the BMP-2 groups |
Bone mineral density measurement |
— |
QCT analyses showed higher mineral density in the adenoviral BMP-2 |
— |
DXA measurements revealed higher BMD in the BMP-2 groups (data not presented) |